MTOR and neoplasm with perivascular epithelioid cell differentiation: Other treatment modalities, including cytotoxic chemotherapy, tyrosine kinase inhibitors, and antiangiogenic agents, have also been used for patients with PEComas, but are overall less studied and not as effective as mTOR inhibitors (refs. 17–19; Supplementary Table S1).